Ampicillin
/
|
Campylobacter Not Specified
|
See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Extensive indoor |
77.80 |
|
100 |
Intensive |
72.90 |
|
100 |
|
Amoxicillin And Beta-Lactamase Inhibitor
/
|
Campylobacter Not Specified
|
See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Extensive indoor |
43.00 |
|
100 |
Intensive |
2.70 |
|
100 |
|
Ciprofloxacin
/
|
Campylobacter Not Specified
|
See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Extensive indoor |
96.50 |
|
100 |
Intensive |
96.40 |
|
100 |
|
Norfloxacin
/
|
Campylobacter Not Specified
|
See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Extensive indoor |
91.30 |
|
100 |
Intensive |
95.90 |
|
100 |
|
Ofloxacin
/
|
Campylobacter Not Specified
|
See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Extensive indoor |
90.50 |
|
100 |
Intensive |
95.40 |
|
100 |
|
Nalidixic Acid
/
|
Campylobacter Not Specified
|
See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Extensive indoor |
97.30 |
|
100 |
Intensive |
97.90 |
|
100 |
|
Erythromycin
/
|
Campylobacter Not Specified
|
See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Extensive indoor |
26.80 |
|
100 |
Intensive |
25.60 |
|
100 |
|
Tetracycline
/
|
Campylobacter Not Specified
|
See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Extensive indoor |
73.60 |
|
100 |
Intensive |
82.90 |
|
100 |
|
Sulfamethoxazole And Trimethoprim
/
|
Campylobacter Not Specified
|
See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Extensive indoor |
26.40 |
|
100 |
Intensive |
48.60 |
|
100 |
|
Chloramphenicol
/
|
Campylobacter Not Specified
|
See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Extensive indoor |
47.00 |
|
100 |
Intensive |
0.80 |
|
100 |
|
Gentamicin
/
|
Campylobacter Not Specified
|
See: Table 5 |
AMR+ (%) |
AMR- (%) |
Total (n) |
Extensive indoor |
13.20 |
|
100 |
Intensive |
0.80 |
|
100 |
|